895
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Occupational health and safety in cannabis production: an Australian perspective

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 75-85 | Received 08 Feb 2018, Accepted 25 Aug 2018, Published online: 03 Oct 2018

References

  • Narcotic Drugs Act 1967, C2016C01132. 2016.
  • Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, 1961.
  • Belackova V, Ritter A, Shanahan M, et al. Medicinal cannabis in Australia – framing the regulatory options. Sydney: National Drug and Alcohol Research Centre, UNSW Australia; 2015.
  • University of Sydney. Medicinal cannabis in Australia: science, regulation & industry. Sydney Australia; 2016.
  • NSW Government. Review of the medicinal cannabis compassionate use scheme sydney. Sydney Australia: NSW Government; 2017.
  • Deloitte Access Economics. Modelling the cost of medicinal cannabis. Control DoH-OoD, editor. Canberra: Department of Health - Office of Drug Control; 2016.
  • Cole C, Zurb B. Industrial hemp - a new crop. Wagga Wagga: NSW Department of Primary Industries; 2008.
  • Maier SL, Mannes S, Koppenhofer EL. The implications of marijuana decriminalization and legalization on crime in the United States. Contemp Drug Probl. 2017;44(2):125–146.
  • Ghosh TS, Vigil DI, Maffey A, et al. Lessons learned after three years of legalized, recreational marijuana: the Colorado experience. Prev Med. 2017;104:4–6.
  • Carnevale JT, Kagan R, Murphy PJ, et al. A practical framework for regulating for-profit recreational marijuana in US states: lessons from Colorado and Washington. Int J Drug Policy. 2017;42:71–85.
  • Kim HS, Hall KE, Genco EK, et al. Marijuana tourism and emergency department visits in Colorado. New England J Med. 2016;374(8):797–798.
  • Barbero A, Flores R. Dust disease in hemp workers. Arch Environ Health: Int J. 1967;14(4):529–532.
  • El Ghawabi S. Respiratory function and symptoms in workers exposed simultaneously to jute and hemp. Occup Environ Med. 1978;35(1):16–20.
  • Fishwick D, Allan L, Wright A, et al. Respiratory symptoms, lung function and cell surface markers in a group of hemp fiber processors. Am J Ind Med. 2001;39(4):419–425.
  • Valić F, Žuškin E. Annual decline of ventilatory capacity and change in acute respiratory response in hemp exposure over a 10-year period. Internationales Archiv für Arbeitsmedizin. 1974;33(3):237–243.
  • Zuskin E, Kanceljak B, Pokrajac D, et al. Respiratory symptoms and lung function in hemp workers. Occup Environ Med. 1990;47(9):627–632.
  • Zuskin E, Kanceljak B, Schachter EN, et al. Immunological findings in hemp workers. Environ Res. 1992;59(2):350–361.
  • Žuškin E, Valić F. Peak flow rate in relation to forced expiratory volume in hemp workers. Occup Environ Med. 1971;28(2):159–163.
  • Herzinger T, Schöpf P, Przybilla B, et al. IgE-mediated hypersensitivity reactions to cannabis in laboratory personnel. Int Arch Allergy Immunol. 2011;156(4):423–426.
  • Victory K, Lowe B, Burton NC, et al. Evaluation of potential hazards during harvesting and processing cannabis at an outdoor organic farm. Cinncinati: U.S. Department of Health and Human Services Centers for Disease Control and Prevention; 2017.
  • Walters KM, Fisher GG, Tenney L, et al. Work and well-being in the Colorado cannabis industry.Colorado: CDC/NIOSH Mountain and Plains Education and Research Center; 2017.
  • Potter DJ. Cannabis horticulture. In: Pertwee RG, editor. Handbook of cannabis. Oxford, UK: Oxford University Press; 2014. p. 65–88.
  • Emboden WA. Cannabis—a polytypic genus. Econ Bot. 1974;28(3):304.
  • Hillig KW. Genetic evidence for speciation in cannabis (Cannabaceae). Genet Resour Crop Evol. 2005;52(2):161–180.
  • Chandra S, Lata H, ElSohly MA, et al. Cannabis cultivation: methodological issues for obtaining medical-grade product. Epilepsy Behav. 2017;70:302–312.
  • ElSohly MA, Radwan MM, Gul W, et al. Phytochemistry of Cannabis sativa L.In: Douglas AK, Gibbons HF, Kobayashi J editors, Phytocannabinoids. Springer; 2017. p. 1–36.
  • Rubin V. Cannabis and culture: Walter de Gruyter; The Hague. 1975.
  • Small E Classification of Cannabis sativa L. in relation to agricultural, biotechnological, medical and recreational utilization. In: Cannabis sativa L-botany and biotechnology. Cham: Springer; 2017. p. 1–62.
  • Fike J. Industrial hemp: renewed opportunities for an ancient crop. CRC Crit Rev Plant Sci. 2016;35(5–6):406–424.
  • ElSohly M, Gul W. Constituents of Cannabis sativa. In: Handbook of cannabis. London: Oxford University Press; 2014. p. 3.
  • Galal AM, Slade D, Gul W, et al. Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. Recent Pat CNS Drug Discov. 2009;4(2):112–136.
  • Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–1364.
  • Russo EB, Marcu J. Cannabis pharmacology: the usual suspects and a few promising leads. Adv Pharmacol. 2017;80: 67–134. Elsevier.
  • Jiggens J. Sir Joseph Banks and the question of hemp: hemp, seapower and empire, 1776–1815. Australia: Indooroopilly; 2012.
  • MARIHUANA DRUG IS BANNED. The Sun. 1938 Sat 27 Aug.
  • Crawford F, Deards B, Moir B, et al. Human consumption of hemp seed: prospects for Australian production. Canberra: ABARES; 2012.
  • ODC. Medicinal cannabis Canberra: office of drug control; 2017 [cited 2017 Jun 2]. Available from: https://www.odc.gov.au/qa.
  • Bisetti AA. Bernardino Ramazzini and occupational lung medicine. Ann N Y Acad Sci. 1988;534(1):1029–1037.
  • Liskow B, Liss JL, Parker CW. Allergy to marihuana. Ann Intern Med. 1971;75(4):571–573.
  • Stadtmauer G, Beyer K, Bardina L, et al. Anaphylaxis to ingestion of hempseed (Cannabis sativa). J Allergy Clin Immunol. 2003;112(1):216–217.
  • Stöckli SS, Bircher AJ. Generalized pruritus in a patient sensitized to tobacco and cannabis. JDDG. 2007;5(4):303–304.
  • Aldington. Effects of cannabis on pulmonary structure, function and symptoms (vol 62, pg 1058, 2007). THORAX. 2008;63(4):385.
  • Basharat P, Sussman G, Beezhold D, et al. Hypersensitivity reactions to marijuana. J Allergy Clin Immunol. 2011;127(2):AB178.
  • Kagen SL, Kurup VP, Sohnle PG, et al. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol. 1983;71(4):389–393.
  • Kumar R, Gupta N. A case of bronchial asthma and allergic rhinitis exacerbated during Cannabis pollination and subsequently controlled by subcutaneous immunotherapy. Indian J Allergy, Asthma and Immunol. 2013;27:143.
  • Abbas HS, Katelaris BC, Singh MA, et al. World allergy organization study on aerobiology for creating first pollen and mold calendar with clinical significance in Islamabad. Pakistan World Allergy Organ J. 2012;5(9):103–110.
  • Aboulaich N, Trigo MM, Bouziane H, et al. Variations and origin of the atmospheric pollen of cannabis detected in the province of Tetouan (NW Morocco): 2008–2010. Sci Total Environ. 2013;443(C):413–419.
  • Ebo D, Swerts S, Sabato V, et al. New food allergies in a European non-Mediterranean region: is Cannabis sativa to blame? Int Arch Allergy Immunol. 2013;161(3):220–228.
  • Macher J. Bioaerosols: assessment and control. Cinncinnati: ACGIH; 1999.
  • Donham K. Agricultural medicine: rural occupational and environmental health, safety, and prevention. 2nd ed. Hoboken: John Wiley & Sons; 2016.
  • Bouhuys A, Barbero A, Schilling RSF, et al. Chronic respiratory disease in hemp workers. Am J Med. 1969;46(4):526–537.
  • Bouhuys A, Gilson JC, Rs S. Byssinosis in the textile industry. Arch Environ Health: Int J. 1970;21(4):475–478.
  • Bouhuys A, Heaphy LJ, Schilling RS, et al. Byssinosis in the United States. N Engl J Med. 1968;278(9):509.
  • Zuskin E, Mustajbegovic J, En S. Follow-up study of respiratory function in hemp workers. Am J Ind Med. 1994;26(1):103–115.
  • Harbison R, Bourgeois M, Johnson G, et al. Hamilton & Hardy’s industrial toxicology. Sixth ed. Hoboken, New Jersey: Wiley; 2015.
  • Fishwick D, Allan L, Wright A, et al. Assessment of exposure to organic dust in a hemp processing plant. Ann Occup Hyg. 2001;45(7):577–583.
  • Noweir M. Studies on the etiology of byssinosis. CHEST. 1988;79(4):62S–7S.
  • McPartland JM. Byssinosis in hemp mill workers. J Ind Hemp. 2003;8(1):33–44.
  • Decuyper I, Ryckebosch H, Gasse A, et al. Cannabis allergy: what do we know Anno 2015. Arch Immunol Ther Exp. 2015;63(5):327–332.
  • Stokes JR, Hartel R, Ford LB, et al. Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy, Asthma Immunol. 2000;85(3):238–240.
  • Nayak AP, Green BJ, Sussman G, et al. Allergenicity to Cannabis sativa L. and methods to assess personal exposure. In: Chandra S, Lata H, ElSohly MA, editors. Cannabis sativa L - botany and biotechnology. Cham: Springer International Publishing; 2017. p. 263–284.
  • Paris M, Boucher F, Cosson L. The constituents of Cannabis sativa pollen. Econ Bot. 1975;29(3):245–253.
  • Haberle SG, Bowman DMJS, Newnham RM, et al. The macroecology of airborne pollen in Australian and New Zealand urban areas. PLOS ONE. 2014;9(5):e97925.
  • Davies JM, Erbas B, Simunovic M, et al. Literature review on thunderstorm asthma and its implications for public health advice. Queensland University of Technology for the Department of Health and Human Services;2017.
  • Vidal C, Fuilnte R, Iglesias A, et al. Bronchial asthma due to Cannabis sativa seed. Allergy. 1991;46(8):647–649.
  • Freeman GL. Allergic skin test reactivity to marijuana in the southwest. West J Med. 1983;138(6):829.
  • Gupta BN, Mehrotra NK, Clerk SH, et al. Immunotherapy in hemp workers having respiratory complaints. Indian J Med Sci. 1980;34(4):72.
  • McKernan K, Spangler J, Helbert Y, et al. Metagenomic analysis of medicinal cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests. F1000Research. 2016. p. 5.
  • Martyny JW, Serrano KA, Schaeffer JW, et al. Potential exposures associated with indoor marijuana growing operations. J Occup Environ Hyg. 2013;10:11.
  • Hansen VM, Winding A, Madsen AM. Exposure to bioaerosols during the growth season of tomatoes in an organic greenhouse using Supresivit (Trichoderma harzianum) and Mycostop (Streptomyces griseoviridis). Appl Environ Microbiol. 2010;76(17):5874.
  • Adhikari A, Gupta J, Wilkins JR, et al. Airborne microorganisms, endotoxin, and (1→3)-β- D -glucan exposure in greenhouses and assessment of respiratory symptoms among workers. Ann Occup Hyg. 2011;55(3):272–285.
  • Hansen VM, Meyling NV, Winding A, et al. Factors affecting vegetable growers’ exposure to fungal bioaerosols and airborne dust. Ann Occup Hyg. 2012;56(2):170–181.
  • Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med. 2012;33(1):151–163.
  • Pepys J, Jenkins PA, Festenstein GN, et al. Farmer’s lung thermophilic Actinomycetes as a source of “farmer’s lung hay” antigen. The Lancet. 1963;282(7308):607–611.
  • Douwes J, Thorne P, Pearce N, et al. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47(3):187–200.
  • Canada Health. Pathogen safety data sheets: government of Canada; 2018 [cited 2018 Aug 21]. Available from: https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/enterococcus-faecalis.html.
  • Hood L, Dames M, Barry G. Headspace volatiles of marijuana. Nature. 1973;242(5397):402.
  • Spiewak R, Gora A, Dutkiewicz J. Work-related skin symptoms and type I allergy among eastern-Polish farmers growing hops and other crops. Ann Agric Environ Med. 2001;8(1):51–56.
  • Eriksson KA, Stjernberg NL, Levin JO, et al. Terpene exposure and respiratory effects among sawmill workers. Scand J Work Environ Health. 1996;22(3):182–190.
  • Hessel PA, Herbert FA, Melenka LS, et al. Lung health in sawmill workers exposed to pine and spruce. Chest. 1995;108(3):642–646.
  • GESTIS. GESTIS substance database Germany: GESTIS; [ cited 2017 Nov 9]. Available from: http://gestis-en.itrust.de.
  • Doran GS, Deans R, De Filippis C, et al. The presence of licit and illicit drugs in police stations and their implications for workplace drug testing. Forensic Sci Int. 2017;278:125–136.
  • Doran GS, Deans R, De Filippis C, et al. Work place drug testing of police officers after THC exposure during large volume cannabis seizures. Forensic Sci Int. 2017;275:224–233.
  • Dryburgh LM, Bolan NS, Grof CPL, et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol. 2018. DOI:10.1111/bcp.13695.
  • Editorial. Ban butane hash oil extraction. The Denver Post. 2014 5 September.
  • Hidta RM. Hash oil extraction hazards: safety for first responders 2014 [cited 2018 Feb 21]. Available from: http://www.rmhidta.org/html/Hash%20Oil%20Extraction%20Explosions.pdf.
  • Busick J. Supercritical CO2: the green solution that created a deadly hazard: EHS daily advisor; 2016 [cited 2017 Nov 9]. Available from: https://ehsdailyadvisor.blr.com/2016/06/supercritical-co2-the-green-solution-that-created-a-deadly-hazard/.
  • Lucas S, Alonso E, Sanz JA, et al. Safety study in a supercritical extraction plant. Chem Eng Technol. 2003;26(4):449–461.
  • Hazekamp A. Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis. Front Pharmacol. 2016;7:108.
  • Zuskin E, Valic F, Bouhuys A. Byssinosis and airway responses due to exposure to textile dust. Lung. 1976;154(1):17–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.